Incannex Healthcare - Spotlight on Incannex’s progress in psychedelics
Incannex, an Australian-based biotech, has several active studies investigating cannabinoid combinations for a range of conditions, but is also...
412 Views
Incannex Healthcare - On the road to psychotherapy clinics
Incannex has announced that it has entered into a lease for its first ‘psychedelic clinic’ in Melbourne, following the announcement of plans for...
375 Views
Incannex Healthcare - On to Phase II for IHL-675A
Incannex has reported final results from its Phase I trial assessing the safety and pharmacokinetics (PK) of IHL-675A, a cannabidiol (CBD) and...
214 Views
Incannex Healthcare - A clinically active quarter
Incannex has released its Q323 cash flow report, providing key operational highlights. Clinical developments during the quarter included a positive...
167 Views
No more insights